4,8,15,19,26-Pentamethyl-3,7,14,18,25-pentaoxa-11,22,27,28,29,30,31-heptazahexacyclo[22.2.1.12,5.16,9.113,16.117,20]hentriaconta-1(26),2(31),4,6(30),8,13(29),15,17(28),19,24(27)-decaene-10,21-dione | 1310540-14-7

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 大环内酰胺类
• 英文名称: 4,8,15,19,26-Pentamethyl-3,7,14,18,25-pentaoxa-11,22,27,28,29,30,31-heptazahexacyclo[22.2.1.12,5.16,9.113,16.117,20]hentriaconta-1(26),2(31),4,6(30),8,13(29),15,17(28),19,24(27)-decaene-10,21-dione
• CAS: 1310540-14-7
• 化学式: C₂₄H₂₁N₇O₇
• 分子量: 519.5
• InChiKey: CZCOTIRQLQPQMN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  38
• 可旋转键数：
  0
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  188
• 氢给体数：
  2
• 氢受体数：
  12

文献信息

• NOVEL ANTIBIOTICS
  申请人：PEOPLES Aaron

  公开号：US20120302613A1

  公开（公告）日：2012-11-29

  The invention relates generally to novel antibiotics and their analogs, to processes for the preparation of these novel antibiotics, to pharmaceutical compositions comprising the novel antibiotics; and to methods of using the novel antibiotics to treat or inhibit various disorders.
• [EN] NOVEL ANTIBIOTICS<br/>[FR] NOUVEAUX ANTIBIOTIQUES
  申请人：NOVOBIOTIC PHARMACEUTICALS LLC

  公开号：WO2012162512A1

  公开（公告）日：2012-11-29

  The invention relates generally to novel antibiotics and their analogs, to processes for the preparation of these novel antibiotics, to pharmaceutical compositions comprising the novel antibiotics; and to methods of using the novel antibiotics to treat or inhibit various disorders.